Journal Pre-proof Heart Failure with Carﬁlzomib in Patients with Multiple Myeloma: A Meta-analysis of Randomized Controlled Trials M. RUBAYAT RAHMAN MD , SOMEDEB BALL MD , DHRUBAJYOTI BANDYOPADHYAY MD , PABLO PAZ MD , MOHAMED ELMASSRY MD , WASAWAT VUTTHIKRAIVIT MD , CARL J. LAVIE MD , GREGG C. FONAROW MD. PII: S1071-9164(20)30870-8 DOI: https://doi.org/10.1016/j.cardfail.2020.07.006 Reference: YJCAF 4573 To appear in: Journal of Cardiac Failure Received date: 7 April 2020 Revised date: 10 June 2020 Accepted date: 16 July 2020 Please cite this article as: M. RUBAYAT RAHMAN MD , SOMEDEB BALL MD , DHRUBAJYOTI BANDYOPADHYAY MD , PABLO PAZ MD , MOHAMED ELMASSRY MD , WASAWAT VUTTHIKRAIVIT MD , CARL J. LAVIE MD , GREGG C. FONAROW MD. , Heart Failure with Carﬁlzomib in Patients with Multiple Myeloma: A Meta-analysis of Randomized Controlled Trials, Journal of Cardiac Failure (2020), doi: https://doi.org/10.1016/j.cardfail.2020.07.006 This is a PDF ﬁle of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the deﬁnitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its ﬁnal form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier Inc.